Deutsche Bank
RKDA icon

Deutsche Bank’s Arcadia Biosciences RKDA Stock Holding History

Deutsche Bank’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-275
Closed -$33K – 5207
2019
Q2 		$33K Buy
275
+272
+9,067% +$57.8K ﹤0.01% 4671
2019
Q1 		$0 Buy
+3
New +$627 ﹤0.01% 5384
2018
Q4 		– Sell
-3
Closed – – 5369
2018
Q3 		$0 Sell
3
-35
-92% -$8.79K ﹤0.01% 5522
2018
Q2 		$12K Buy
+38
New +$20.7K ﹤0.01% 5123
2017
Q3 		– Sell
-3
Closed -$1K – 5046
2017
Q2 		$1K Buy
+3
New +$1.67K ﹤0.01% 4871
2016
Q2 		– Sell
-1
Closed -$3K – 5320
2016
Q1 		$3K Sell
1
-2
-67% -$4.25K ﹤0.01% 5017
2015
Q4 		$5K Sell
3
-1
-25% -$2.6K ﹤0.01% 5062
2015
Q3 		$8K Buy
4
+2
+100% +$8.32K ﹤0.01% 4986
2015
Q2 		$12K Buy
+2
New +$12.4K ﹤0.01% 5024

Other funds holding RKDA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAM
Blueshift Asset Management Red Bank, New Jersey $330M AUM 7.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Deutsche Bank's RKDA Position: Q3 2019 in Review

Deutsche Bank sold out of Arcadia Biosciences (RKDA) in Q3 2019, closing a stake of 275 shares — an estimated $33K sold.

Deutsche Bank first reported a position in RKDA in Q2 2015 and held it in 9 quarters. The position peaked at $33K in Q2 2019. 18 funds tracked by Wall St. Rank hold RKDA as of Q3 2019.

  • Deutsche Bank reported no remaining Arcadia Biosciences position as of Q3 2019 after selling out during the quarter.
  • Deutsche Bank sold 275 Arcadia Biosciences shares in Q3 2019, an estimated $33K.
  • Deutsche Bank first reported a position in Arcadia Biosciences in Q2 2015 and held it in 9 quarters.
  • Deutsche Bank's Arcadia Biosciences position peaked at $33K in Q2 2019.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.